2018_Fa Makayla, Adam & Ben: Healthcare that Cares

Colgate University Public Economics Course

Το περιεχόμενο παρέχεται από το Daniel Ludwinski and Professor Daniel Ludwinski. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Daniel Ludwinski and Professor Daniel Ludwinski ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.

5+ y ago 15:14

M4A•Αρχική οθόνη επεισοδίου

Fetch error

Hmmm there seems to be a problem fetching this series right now. Last successful fetch was on June 28, 2019 13:41 (5y ago)

What now? This series will be checked again in the next day. If you believe it should be working, please verify the publisher's feed link below is valid and includes actual episode links. You can contact support to request the feed be immediately fetched.

In this podcast Makayla, Ben, and Adam discuss drug pricing in the pharmaceutical industry. In recent years, there has been a sharp increase in the cost of pharmaceutical drugs. This has not only become a problem for patients, but for prescribers, payers, and policy makers. The pharmaceutical industry is a unique industry because the end user is not normally the one that pays for the prescription drug. Drug pricing in the US is not transparent. With the help of Mike Cropp, President and CEO of Independent Health, and John Rodgers, COO of Independent Health, Makayla, Ben, and Adam explore the reasons why the drug market is skewed, the difficulties of pricing drugs, and potential strategies to counter high prices.

32 επεισόδια

#Higher Education #Economics #Government #Public Policy #Economy #Course #Colgate #Colgate University #Daniel Ludwinski #Professor Daniel Ludwinski #Podcasting Education